Patient journey: key within the combination product ecosystem


Patient experience integration: foundation to a successful injectable device strategy

The growing prevalence of chronic diseases along with the evolution of patients’ lifestyles are driving new ways of administrating parenteral drugs. Novel treatments have become available, with the majority arising from biological molecules as well as high-value drugs. Biologic drugs are predominantly administered via injectable devices, using prefilled syringes as a base. A pipeline of more than 3000 biologics are under development today which clearly shows a need of a more complex drug delivery device with advanced technology. On top of that, the rising trend of high-value drugs delivery from intravenous to subcutaneous in homecare setting and self-administration requires easy-to-use devices, designed through human factor studies particularly for patients’ safety and comfort.

In order to achieve successful drug delivery device development, it is crucial to understand the universe of the industry thoroughly to be able to build a sustainable strategy. As a matter of fact, patients should be at the heart of the ecosystem: regulatory environment, technology advancement, healthcare providers, as well as the payer policies. In the interest of ensuring successful combination product development, it is fundamental to have a broader comprehension of each stakeholder. The purpose is to eventually assess technology selections to innovate a safe and effective device, to ultimately help affirm seamless delivery of care to patients and help them tackle the challenges that they encounter such as needlestick phobia and pain during injection.

Understanding the patient journey has become one of the most critical foundations for innovation. The device itself must be also considered within the larger context of the combination product. This can be supported through user experience and human factor studies which have become critical to differentiate and to answer patients’ unmet needs – for instance in terms of packaging, instructions, connectivity/digital health integration…

As a world leader in design development and manufacturing, Nemera provides useful advice to ensure successful development of patient-focused parenteral combination products with integrated services. Along with parenteral our expertise extends in other application areas such as ophthalmic, nasal, dermal and inhalation. Please join us and sign-up today to gain a greater understanding of the importance of integrating patients in various stages of combination product development as well as to learn more on leveraging the patient journey. We will present how to concretely implement patient-centric strategy holistically in order to ensure ideal injectable device for the target population with a differentiated user experience. This overview will be illustrated through a case study example based on our experiences around pens and autoinjectors, as well as our premium add-on passive safety device, Safe’n’Sound® and on-body injector/wearable platform.

Presented by

Mark Tunkel,

Business Development Director

Director of Business Development for Nemera’s Insight Innovation Center. With more than 20 years of global business development experience and a deep understanding of the marketplace challenges and trends impacting the pharma industry, Mr Tunkel has advised many of the world’s leading companies on their product development and innovation strategies, with an emphasis on driving realisation and the most favourable business outcomes.

Severine Duband,

Global Category Manager – Parenteral

Global Category Manager at Nemera in charge of the parenteral range of proprietary products including Safe’n’Sound®, the passive safety device platform for prefilled syringes. Ms Duband joined Nemera in 2018. She has 10 years’ marketing experience in fast-moving consumer goods, with key competencies including strategic planning, new product development launches, project management, brand communication and team leadership in an international environment. Ms Duband has an MSc in Business Marketing from Emlyon Business School (Lyon, France).

Audrey Chandra,

Category Manager – Parenteral

Audrey Pamila Chandra is the Category Manager for the Parenteral segment at Nemera.
She believes that the ease of use of the device plays an important role towards the patients’ quality of life. She is in charge of identifying the pain points and the unmet needs of the patients, as well as accompanying product development in parallel. Ms. Chandra joined Nemera in February 2019 with her dual competence. She graduated from Faculty of Medicine in Indonesia and she pursued her Master studies in Strategy and Business Development in Toulouse School of Management, France.

Key Learning Objectives

  • The key converging mega trends and their implications on parenteral devices
  • How to navigate through the combination product ecosystem and build a successful strategy from user requirements to device selection
  • Overview of understanding the patient journey as a key foundation
  • Illustration of patient centricity integration within development phases of passive safety system and on-body injectors


  • Head of device development
  • Innovation team
  • Project manager
  • Product manager
  • Procurement
  • Business Development (Pharma and Generics)
  • Regulatory manager
  • Quality manager